{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:42:37Z","timestamp":1760186557569,"version":"build-2065373602"},"reference-count":116,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.hoc.2013.11.002","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T02:30:40Z","timestamp":1390530640000},"page":"249-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Does Erythropoietin Have a Role in the Treatment of \u03b2-Hemoglobinopathies?"],"prefix":"10.1016","volume":"28","author":[{"given":"Eitan","family":"Fibach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliezer A.","family":"Rachmilewitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.hoc.2013.11.002_bib1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V77.3.419.419","article-title":"Erythropoietin","volume":"77","author":"Krantz","year":"1991","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2013.11.002_bib2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1152\/physrev.1992.72.2.449","article-title":"Erythropoietin: structure, control of production, and function","volume":"72","author":"Jelkmann","year":"1992","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.hoc.2013.11.002_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.seminhematol.2007.04.004","article-title":"Risks and benefits of erythropoiesis-stimulating agents in cancer management","volume":"44","author":"Beutel","year":"2007","journal-title":"Semin Hematol"},{"issue":"11","key":"10.1016\/j.hoc.2013.11.002_bib4","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1681\/ASN.V4111874","article-title":"Effect of erythrocyte mass on arterial blood pressure in dialysis patients receiving maintenance erythropoietin therapy","volume":"4","author":"Kaupke","year":"1994","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.hoc.2013.11.002_bib5","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/01.ASN.0000013294.11876.80","article-title":"Trends in anemia management among US hemodialysis patients","volume":"13","author":"Coladonato","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.hoc.2013.11.002_bib6","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1097\/01.ASN.0000016440.52271.F7","article-title":"Anemia management in chronic kidney disease: role of factors affecting epoetin responsiveness","volume":"13","author":"Eschbach","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"Suppl 3","key":"10.1016\/j.hoc.2013.11.002_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1634\/theoncologist.2011-S3-35","article-title":"Clinical use of erythropoietic stimulating agents in myelodysplastic syndromes","volume":"16","author":"Santini","year":"2011","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.hoc.2013.11.002_bib8","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJMra050436","article-title":"Beta-thalassemia","volume":"353","author":"Rund","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2013.11.002_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0609.1986.tb02301.x","article-title":"Erythropoietin activity in the serum of beta thalassemic patients","volume":"37","author":"Manor","year":"1986","journal-title":"Scand J Haematol"},{"issue":"4","key":"10.1016\/j.hoc.2013.11.002_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01695865","article-title":"Serum erythropoietin levels in thalassemia intermedia","volume":"67","author":"Dore","year":"1993","journal-title":"Ann Hematol"},{"issue":"21","key":"10.1016\/j.hoc.2013.11.002_bib11","doi-asserted-by":"crossref","first-page":"A3242","DOI":"10.1182\/blood.V120.21.3242.3242","article-title":"Erythropoietin levels in patients with sickle cell disease not in vaso-occlusive crisis","volume":"120","author":"Pulte","year":"2012","journal-title":"Blood"},{"issue":"3 Suppl 9","key":"10.1016\/j.hoc.2013.11.002_bib12","first-page":"74","article-title":"Hydroxyurea and erythropoietin therapy in sickle cell anemia","volume":"19","author":"Goldberg","year":"1992","journal-title":"Semin Oncol"},{"issue":"12","key":"10.1016\/j.hoc.2013.11.002_bib13","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1182\/blood.V80.12.3258.3258","article-title":"Trial of recombinant human erythropoietin: three patients with thalassemia intermedia","volume":"80","author":"Olivieri","year":"1992","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2013.11.002_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2141.1995.tb05156.x","article-title":"Sustained increase in haemoglobin and RBC following long-term administration of recombinant human erythropoietin to patients with homozygous beta-thalassaemia","volume":"90","author":"Rachmilewitz","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2013.11.002_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1749-6632.1998.tb10470.x","article-title":"The role of recombinant human erythropoietin in the treatment of thalassemia","volume":"850","author":"Rachmilewitz","year":"1998","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"10.1016\/j.hoc.2013.11.002_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00043426-200212000-00021","article-title":"Use of hydroxyurea and recombinant erythropoietin in management of homozygous beta0 thalassemia","volume":"24","author":"Kohli-Kumar","year":"2002","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2013.11.002_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000077551","article-title":"Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules","volume":"111","author":"Chaidos","year":"2004","journal-title":"Acta Haematol"},{"issue":"2","key":"10.1016\/j.hoc.2013.11.002_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2141.2011.08617.x","article-title":"Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes","volume":"154","author":"Singer","year":"2011","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.hoc.2013.11.002_bib19","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood.V94.6.1864","article-title":"Regulation of the erythropoietin gene","volume":"94","author":"Ebert","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2013.11.002_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1101\/SQB.1995.060.01.012","article-title":"The erythropoietin receptor: biogenesis, dimerization, and intracellular signal transduction","volume":"60","author":"Lodish","year":"1995","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"12","key":"10.1016\/j.hoc.2013.11.002_bib21","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood.V77.12.2583.2583","article-title":"Erythropoietin receptor characteristics on primary human erythroid cells","volume":"77","author":"Broudy","year":"1991","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2013.11.002_bib22","first-page":"S84","article-title":"The roles of Jaks and Stats in cytokine signaling","volume":"4","author":"Ihle","year":"1998","journal-title":"Cancer J Sci Am"},{"issue":"3","key":"10.1016\/j.hoc.2013.11.002_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MOH.0b013e32832990a4","article-title":"Ineffective erythropoiesis and thalassemias","volume":"16","author":"Rivella","year":"2009","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2141.2000.02145.x","article-title":"Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways","volume":"110","author":"Sui","year":"2000","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib25","first-page":"24","article-title":"Reactivation of fetal hemoglobin in patients with beta-thalassemia","volume":"33","author":"Olivieri","year":"1996","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1016\/j.hoc.2013.11.002_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/092986707779313318","article-title":"Medicinal chemistry of fetal hemoglobin inducers for treatment of beta-thalassemia","volume":"14","author":"Gambari","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.hoc.2013.11.002_bib27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/asheducation-2009.1.62","article-title":"Advances in the use of hydroxyurea","author":"Ware","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"10.1016\/j.hoc.2013.11.002_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1172\/JCI200316672","article-title":"Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase","volume":"111","author":"Cokic","year":"2003","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.1994.tb04974.x","article-title":"Reducing erythropoietin in cultures of human erythroid precursors elevates the proportion of fetal haemoglobin","volume":"88","author":"Fibach","year":"1994","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.hoc.2013.11.002_bib30","first-page":"1141","article-title":"Adult and neonatal patterns of human globin gene expression are recapitulated in liquid cultures","volume":"20","author":"Dalyot","year":"1992","journal-title":"Exp Hematol"},{"issue":"5","key":"10.1016\/j.hoc.2013.11.002_bib31","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.clinthera.2009.05.013","volume":"31","author":"Cho","year":"2009","journal-title":"Clin Ther"},{"issue":"Suppl 5","key":"10.1016\/j.hoc.2013.11.002_bib32","first-page":"200","article-title":"Fetal erythropoiesis in stress hematopoiesis","volume":"7","author":"Alter","year":"1979","journal-title":"Exp Hematol"},{"issue":"2","key":"10.1016\/j.hoc.2013.11.002_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000204179","article-title":"Fetal globin stimulation during a short-term trial of erythropoietin in HbS\/beta-thalassemia patients","volume":"92","author":"Bourantas","year":"1994","journal-title":"Acta Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib34","first-page":"1","article-title":"Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy","volume":"8","author":"Breymann","year":"1999","journal-title":"J\u00a0Matern Fetal Med"},{"issue":"8","key":"10.1016\/j.hoc.2013.11.002_bib35","first-page":"1076","article-title":"Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review","volume":"91","author":"Little","year":"2006","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.hoc.2013.11.002_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199301143280201","article-title":"Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease","volume":"328","author":"Rodgers","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2013.11.002_bib37","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.3218.3218","article-title":"Clinical efficacy and safety of erythroid stimulating agents in sickle cell disease","volume":"120","author":"Saraf","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2013.11.002_bib38","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3324\/haematol.2012.066845","article-title":"Non-transfusion-dependent thalassemias","volume":"98","author":"Musallam","year":"2013","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.hoc.2013.11.002_bib39","first-page":"184","article-title":"Growth differentiation factor 15 in erythroid health and disease","volume":"17","author":"Tanno","year":"2010","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2013.11.002_bib40","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/BJ20101825","article-title":"Regulation of cellular iron metabolism","volume":"434","author":"Wang","year":"2011","journal-title":"Biochem J"},{"key":"10.1016\/j.hoc.2013.11.002_bib41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4615-2554-7_21","article-title":"Cellular ferritin uptake: a highly regulated pathway for iron assimilation in human erythroid precursor cells","volume":"356","author":"Konijn","year":"1994","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.hoc.2013.11.002_bib42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0955-3886(00)00087-4","article-title":"The importance of non-transferrin bound iron in disorders of iron metabolism","volume":"23","author":"Breuer","year":"2000","journal-title":"Transfus Sci"},{"issue":"2","key":"10.1016\/j.hoc.2013.11.002_bib43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2141.2008.07192.x","article-title":"The labile iron pool in human erythroid cells","volume":"142","author":"Prus","year":"2008","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2013.11.002_bib44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood.V50.3.433.433","article-title":"Low molecular weight intracellular iron transport compounds","volume":"50","author":"Jacobs","year":"1977","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0609.2012.01783.x","article-title":"Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron","volume":"89","author":"Ghoti","year":"2012","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib46","first-page":"145","article-title":"Oxidative stress in patients with beta-thalassemia major","volume":"28","author":"Pavlova","year":"2007","journal-title":"Prilozi"},{"issue":"9","key":"10.1016\/j.hoc.2013.11.002_bib47","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1440-1681.2007.04639.x","article-title":"Sickle cell disease: role of reactive oxygen and nitrogen metabolites","volume":"34","author":"Wood","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"10.1016\/j.hoc.2013.11.002_bib48","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1525-1373.1999.d01-144.x","article-title":"Interaction of antioxidants and their implication in genetic anemia","volume":"222","author":"Chan","year":"1999","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib49","first-page":"70","article-title":"Oxidative denaturation of red blood cells in thalassemia","volume":"27","author":"Shinar","year":"1990","journal-title":"Semin Hematol"},{"key":"10.1016\/j.hoc.2013.11.002_bib50","first-page":"241","article-title":"Intermediate hemichrome formation after oxidation of three unstable hemoglobins (Freiburg, Riverdale-Bronx and Koln)","volume":"10","author":"Rachmilewitz","year":"1972","journal-title":"Hamatol Bluttransfus"},{"issue":"4","key":"10.1016\/j.hoc.2013.11.002_bib51","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1182\/blood.V79.4.1058.bloodjournal7941058","article-title":"Characterization and comparison of the red blood cell membrane damage in severe human alpha- and beta-thalassemia","volume":"79","author":"Advani","year":"1992","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib52","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/cyto.a.20017","article-title":"Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells","volume":"60","author":"Amer","year":"2004","journal-title":"Cytometry A"},{"issue":"5","key":"10.1016\/j.hoc.2013.11.002_bib53","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bbagen.2006.01.012","article-title":"Oxidative status of valinomycin-resistant normal, beta-thalassemia and sickle red blood cells","volume":"1760","author":"Amer","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"7\u20138","key":"10.1016\/j.hoc.2013.11.002_bib54","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1089\/ars.2006.8.1183","article-title":"Mechanisms and significance of eryptosis","volume":"8","author":"Lang","year":"2006","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"10.1016\/j.hoc.2013.11.002_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbagen.2007.11.009","article-title":"N-acetylcysteine amide (AD4) attenuates oxidative stress in beta-thalassemia blood cells","volume":"1780","author":"Amer","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.hoc.2013.11.002_bib56","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2141.2005.05463.x","article-title":"Chronic oxidative stress reduces the respiratory burst response of neutrophils from beta-thalassaemia patients","volume":"129","author":"Amer","year":"2005","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood.V99.1.36","article-title":"The hypercoagulable state in thalassemia","volume":"99","author":"Eldor","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2013.11.002_bib58","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0885-4505(86)90066-6","article-title":"Effect of erythropoietin on the interchange of cholesterol and phospholipid between erythrocyte membrane and plasma","volume":"35","author":"Biswas","year":"1986","journal-title":"Biochem Med Metab Biol"},{"issue":"3","key":"10.1016\/j.hoc.2013.11.002_bib59","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1203\/00006450-199609000-00003","article-title":"Recombinant human erythropoietin: possible role as an antioxidant in premature rabbits","volume":"40","author":"Bany-Mohammed","year":"1996","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.hoc.2013.11.002_bib60","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000086406","article-title":"Mechanisms of suicidal erythrocyte death","volume":"15","author":"Lang","year":"2005","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"10.1016\/j.hoc.2013.11.002_bib61","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00232-011-9345-y","article-title":"Oxidative stress-induced membrane shedding from RBCs is Ca flux-mediated and affects membrane lipid composition","volume":"240","author":"Freikman","year":"2011","journal-title":"J\u00a0Membr Biol"},{"issue":"6","key":"10.1016\/j.hoc.2013.11.002_bib62","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/BF00866497","article-title":"The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure","volume":"6","author":"Turi","year":"1992","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.hoc.2013.11.002_bib63","first-page":"24","article-title":"The effect of human recombinant erythropoietin on the lipid peroxidation processes and antioxidant protection of the erythrocytes in patients with chronic kidney failure on hemodialysis","volume":"38","author":"Rud'ko","year":"1993","journal-title":"Gematol Transfuziol"},{"issue":"4","key":"10.1016\/j.hoc.2013.11.002_bib64","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000188510","article-title":"Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron","volume":"69","author":"Delmas-Beauvieux","year":"1995","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.hoc.2013.11.002_bib65","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/00365599709030622","article-title":"Lipid peroxidation and antioxidant activity in chronic haemodialysis patients treated with recombinant human erythropoietin","volume":"31","author":"Cavdar","year":"1997","journal-title":"Scand J Urol Nephrol"},{"issue":"10","key":"10.1016\/j.hoc.2013.11.002_bib66","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/ndt\/13.10.2583","article-title":"Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients?","volume":"13","author":"Sommerburg","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.hoc.2013.11.002_bib67","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF02550233","article-title":"Red cell lipid peroxidation and antioxidant system in haemodialysed patients: influence of recombinant human erythropoietin (r-HuEPO) treatment","volume":"30","author":"Boran","year":"1998","journal-title":"Int Urol Nephrol"},{"issue":"9","key":"10.1016\/j.hoc.2013.11.002_bib68","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1681\/ASN.V1091982","article-title":"Increased erythrocyte phosphatidylserine exposure in chronic renal failure","volume":"10","author":"Bonomini","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.hoc.2013.11.002_bib69","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1097\/01.ASN.0000093253.42641.C1","article-title":"Inhibition of erythrocyte cation channels by erythropoietin","volume":"14","author":"Myssina","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.hoc.2013.11.002_bib70","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1681\/ASN.V781178","article-title":"Is erythropoietin a survival factor for red blood cells?","volume":"7","author":"Polenakovic","year":"1996","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.hoc.2013.11.002_bib71","doi-asserted-by":"crossref","first-page":"978710","DOI":"10.1155\/2010\/978710","article-title":"The antioxidant effect of erythropoietin on thalassemic blood cells","volume":"2010","author":"Amer","year":"2010","journal-title":"Anemia"},{"issue":"2","key":"10.1016\/j.hoc.2013.11.002_bib72","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jcp.1041420202","article-title":"Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors","volume":"142","author":"Sawada","year":"1990","journal-title":"J\u00a0Cell Physiol"},{"issue":"2","key":"10.1016\/j.hoc.2013.11.002_bib73","doi-asserted-by":"crossref","first-page":"C378","DOI":"10.1152\/ajpcell.00543.2008","article-title":"Erythropoietin activates nitric oxide synthase in murine erythrocytes","volume":"297","author":"Mihov","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.hoc.2013.11.002_bib74","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1749-6632.1983.tb31675.x","article-title":"Erythropoietin interaction with the mature red cell membrane","volume":"414","author":"Baciu","year":"1983","journal-title":"Ann N Y Acad Sci"},{"issue":"19","key":"10.1016\/j.hoc.2013.11.002_bib75","doi-asserted-by":"crossref","first-page":"9714","DOI":"10.1158\/0008-5472.CAN-05-4280","article-title":"Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells","volume":"66","author":"Pedranzini","year":"2006","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.hoc.2013.11.002_bib76","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1016\/S0021-9258(17)35756-3","article-title":"Structural characterization of human erythropoietin","volume":"261","author":"Lai","year":"1986","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib77","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0003-9861(83)90031-0","article-title":"Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals in the presence of copper salts: a physiologically significant reaction?","volume":"225","author":"Rowley","year":"1983","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"10.1016\/j.hoc.2013.11.002_bib78","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/abbi.1993.1158","article-title":"Structures of mucin-type sugar chains on human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells","volume":"301","author":"Inoue","year":"1993","journal-title":"Arch Biochem Biophys"},{"issue":"13","key":"10.1016\/j.hoc.2013.11.002_bib79","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.febslet.2007.04.062","article-title":"Sialic acid is an essential moiety of mucin as a hydroxyl radical scavenger","volume":"581","author":"Ogasawara","year":"2007","journal-title":"FEBS Lett"},{"issue":"10","key":"10.1016\/j.hoc.2013.11.002_bib80","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.archoralbio.2012.04.019","article-title":"Saliva increases the availability of lipophilic polyphenols as antioxidants and enhances their retention in the oral cavity","volume":"57","author":"Ginsburg","year":"2012","journal-title":"Arch Oral Biol"},{"issue":"16","key":"10.1016\/j.hoc.2013.11.002_bib81","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1046\/j.1432-1327.2001.02379.x","article-title":"Evidence for efficient uptake and incorporation of sialic acid by eukaryotic cells","volume":"268","author":"Oetke","year":"2001","journal-title":"Eur J Biochem"},{"issue":"2","key":"10.1016\/j.hoc.2013.11.002_bib82","first-page":"94","article-title":"Altered sialic acid contents of red blood cell membrane preparations in homozygous beta-thalassemia","volume":"27","author":"Calatroni","year":"1978","journal-title":"Ital J Biochem"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib83","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0005-2736(80)90166-2","article-title":"The erythrocyte membranes in beta-thalassemia. Lower sialic acid levels in glycophorin","volume":"596","author":"Kahane","year":"1980","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"10.1016\/j.hoc.2013.11.002_bib84","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0300-9084(03)00059-2","article-title":"Uptake of sialic acid by human erythrocyte. Characterization of a transport system","volume":"85","author":"Bulai","year":"2003","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.hoc.2013.11.002_bib85","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1006\/bbrc.2001.5053","article-title":"Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants","volume":"284","author":"Yousef","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.hoc.2013.11.002_bib86","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-62703-308-4_2","article-title":"Epo and non-hematopoietic cells: what do we know?","volume":"982","author":"Ogunshola","year":"2013","journal-title":"Methods Mol Biol"},{"issue":"2","key":"10.1016\/j.hoc.2013.11.002_bib87","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1158\/1078-0432.CCR-05-1771","article-title":"Erythropoietin biology in cancer","volume":"12","author":"Hardee","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.hoc.2013.11.002_bib88","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/jpet.107.127357","article-title":"Cellular protection by erythropoietin: new therapeutic implications?","volume":"323","author":"Joyeux-Faure","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.hoc.2013.11.002_bib89","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03402029","article-title":"Erythropoietin therapy for acute stroke is both safe and beneficial","volume":"8","author":"Ehrenreich","year":"2002","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib90","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nbd.2006.08.007","article-title":"Signal transducers and activators of transcription 5 contributes to erythropoietin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia","volume":"25","author":"Zhang","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.1016\/j.hoc.2013.11.002_bib91","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/jir.1997.17.279","article-title":"Identification of genes induced by interleukin-3 and erythropoietin via the Jak-Stat5 pathway using enhanced differential display-reverse southern","volume":"17","author":"Ofir","year":"1997","journal-title":"J\u00a0Interferon Cytokine Res"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib92","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0306-4522(96)00306-5","article-title":"Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in\u00a0vitro glutamate-induced neuronal death","volume":"76","author":"Morishita","year":"1997","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.hoc.2013.11.002_bib93","first-page":"465","article-title":"Erythropoietin is a multifunctional tissue-protective cytokine","volume":"2","author":"Erbayraktar","year":"2003","journal-title":"Curr Hematol Rep"},{"issue":"6","key":"10.1016\/j.hoc.2013.11.002_bib94","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.0409329102","article-title":"A\u00a0nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury","volume":"102","author":"Fiordaliso","year":"2005","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"5681","key":"10.1016\/j.hoc.2013.11.002_bib95","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1098313","article-title":"Derivatives of erythropoietin that are tissue protective but not erythropoietic","volume":"305","author":"Leist","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.hoc.2013.11.002_bib96","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1124\/jpet.105.094854","article-title":"Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties","volume":"316","author":"Moon","year":"2006","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"41","key":"10.1016\/j.hoc.2013.11.002_bib97","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1073\/pnas.0406491101","article-title":"Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor","volume":"101","author":"Brines","year":"2004","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"4","key":"10.1016\/j.hoc.2013.11.002_bib98","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/03630269.2011.588355","article-title":"Malignancies in beta-thalassemia patients: first description of two cases of thyroid cancer and review of the literature","volume":"35","author":"Poggi","year":"2011","journal-title":"Hemoglobin"},{"issue":"6","key":"10.1016\/j.hoc.2013.11.002_bib99","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/pbc.22144","article-title":"Malignancies in patients with beta-thalassemia major and beta-thalassemia intermedia: a multicenter study in Iran","volume":"53","author":"Karimi","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1365-2141.2003.04732.x","article-title":"Hepatocellular carcinoma in the thalassaemia syndromes","volume":"124","author":"Borgna-Pignatti","year":"2004","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.hoc.2013.11.002_bib101","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.amjmed.2008.06.039","article-title":"Iron status and colorectal cancer in symptomatic elderly patients","volume":"121","author":"Joosten","year":"2008","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib102","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1349-7006.2008.01001.x","article-title":"Role of iron in carcinogenesis: cancer as a ferrotoxic disease","volume":"100","author":"Toyokuni","year":"2009","journal-title":"Cancer Sci"},{"issue":"12","key":"10.1016\/j.hoc.2013.11.002_bib103","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","article-title":"Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review","volume":"91","author":"Caro","year":"2001","journal-title":"Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2013.11.002_bib104","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0167-8140(91)90183-H","article-title":"What is the importance of anaemia in radiotherapy? The value of animal studies","volume":"20","author":"Hirst","year":"1991","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2013.11.002_bib105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1634\/theoncologist.7-6-492","article-title":"Impact of tumor hypoxia and anemia on radiation therapy outcomes","volume":"7","author":"Harrison","year":"2002","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib106","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0167-8140(96)91811-3","article-title":"Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck","volume":"41","author":"Nordsmark","year":"1996","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.hoc.2013.11.002_bib107","first-page":"3339","article-title":"Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in\u00a0vivo in the FSaIIC murine fibrosarcoma","volume":"50","author":"Teicher","year":"1990","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.hoc.2013.11.002_bib108","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/(SICI)1097-0215(19980821)79:4<365::AID-IJC10>3.0.CO;2-4","article-title":"Tumor hypoxia in pelvic recurrences of cervical cancer","volume":"79","author":"Hockel","year":"1998","journal-title":"Int J Cancer"},{"issue":"3 Suppl 2","key":"10.1016\/j.hoc.2013.11.002_bib109","first-page":"20","article-title":"The impact of epoetin alfa on quality of life during cancer chemotherapy: a fresh look at an old problem","volume":"34","author":"Glaspy","year":"1997","journal-title":"Semin Hematol"},{"issue":"7","key":"10.1016\/j.hoc.2013.11.002_bib110","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jnci\/dji087","article-title":"Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis","volume":"97","author":"Bohlius","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.hoc.2013.11.002_bib111","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1158\/0008-5472.284.65.1","article-title":"Darbepoietin alfa potentiates the efficacy of radiation therapy in mice with corrected or uncorrected anemia","volume":"65","author":"Ning","year":"2005","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.hoc.2013.11.002_bib112","first-page":"1358","article-title":"Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors","volume":"61","author":"Thews","year":"2001","journal-title":"Cancer Res"},{"issue":"9392","key":"10.1016\/j.hoc.2013.11.002_bib113","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","article-title":"Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial","volume":"362","author":"Henke","year":"2003","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.hoc.2013.11.002_bib114","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1200\/JCO.2005.06.150","article-title":"Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study","volume":"23","author":"Leyland-Jones","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2013.11.002_bib115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.0902-4441.2003.00190.x","article-title":"Erythropoietin has an anti-myeloma effect\u2013a hypothesis based on a clinical observation supported by animal studies","volume":"72","author":"Mittelman","year":"2004","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.hoc.2013.11.002_bib116","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1365-2141.2006.06366.x","article-title":"Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?","volume":"135","author":"Prutchi-Sagiv","year":"2006","journal-title":"Br J Haematol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858813001895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858813001895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:00:29Z","timestamp":1760184029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858813001895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":116,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0889858813001895"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2013.11.002","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Erythropoietin Have a Role in the Treatment of \u03b2-Hemoglobinopathies?","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2013.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}